Cipla Signals Lanreotide Supply Strain, Eyes First Wave GLP-1 India Entry

Cipla Scion To Shepherd ‘Value Systems, Growth Agenda’

 
• By Anju Ghangurde
  
Supply issues for key peptide asset may slow Cipla's earnings run
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Therapy Areas